Cullinan Therapeutics (CGEM) Short Interest Ratio & Short Volume $16.02 +0.44 (+2.82%) (As of 11/8/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cullinan Therapeutics Short Interest DataCullinan Therapeutics (CGEM) has a short interest of 9.06 million shares, representing 23.23% of the float (the number of shares available for trading by the public). This marks a -1.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 15.7, indicating that it would take 15.7 days of the average trading volume of 651,644 shares to cover all short positions.Current Short Interest9,060,000 sharesPrevious Short Interest9,210,000 sharesChange Vs. Previous Month-1.63%Dollar Volume Sold Short$147.13 millionShort Interest Ratio15.7 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares57,980,000 sharesFloat Size39,000,000 sharesShort Percent of Float23.23%Today's Trading Volume469,552 sharesAverage Trading Volume651,644 sharesToday's Volume Vs. Average72% Short Selling Cullinan Therapeutics? Sign up to receive the latest short interest report for Cullinan Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCGEM Short Interest Over TimeCGEM Days to Cover Over TimeCGEM Percentage of Float Shorted Over Time Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Cullinan Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20249,060,000 shares $147.13 million -1.6%23.2%15.7 $16.24 9/30/20249,210,000 shares $154.18 million +9.4%23.6%14.2 $16.74 9/15/20248,420,000 shares $151.14 million +4.6%21.6%11.7 $17.95 8/31/20248,050,000 shares $157.78 million -1.4%20.9%10.2 $19.60 8/15/20248,160,000 shares $137.99 million -2.4%21.2%10.3 $16.91 7/31/20248,360,000 shares $161.77 million +6.0%20.6%10 $19.35 Get the Latest News and Ratings for CGEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/20247,890,000 shares $130.90 million +0.6%19.4%8 $16.59 6/30/20247,840,000 shares $136.73 million +73.5%19.3%8 $17.44 6/15/20244,520,000 shares $85.34 million +4.2%10.3%5.1 $18.88 5/31/20244,340,000 shares $101.99 million +16.0%11.0%5.5 $23.50 5/15/20243,740,000 shares $99.93 million +58.5%11.9%5 $26.72 4/30/20242,360,000 shares $63.74 million +40.5%10.2%3.3 $27.01 4/15/20241,680,000 shares $27.80 million +16.7%6.4%3.1 $16.55 3/31/20241,440,000 shares $24.54 million +53.9%5.5%3.4 $17.04 3/15/2024935,400 shares $14.90 million +34.8%3.6%2.3 $15.93 2/29/2024694,100 shares $12.82 million -11.5%2.6%1.8 $18.47 2/15/2024783,900 shares $14.45 million -46.7%2.9%2.3 $18.43 1/31/20241,470,000 shares $22.26 million +34.9%5.4%5.1 $15.14 1/15/20241,090,000 shares $11.54 million +3.8%4.0%5.2 $10.59 12/31/20231,050,000 shares $10.70 million -48.5%3.9%5.4 $10.19 12/15/20232,040,000 shares $16.81 million -3.3%7.5%11.1 $8.24 11/30/20232,110,000 shares $17.28 million -2.3%7.8%12.5 $8.19 11/15/20232,160,000 shares $19.16 million +0.5%8.0%13.3 $8.87 10/31/20232,150,000 shares $20.06 million -1.8%7.9%12.9 $9.33 10/15/20232,190,000 shares $19.27 million -0.5%8.1%12.9 $8.80 9/30/20232,200,000 shares $19.91 million +0.9%8.1%12.1 $9.05 9/15/20232,180,000 shares $21.71 million -17.7%8.0%11.5 $9.96 8/31/20232,650,000 shares $27.43 million +33.2%9.8%10.2 $10.35 8/15/20231,990,000 shares $20.32 million +2.6%7.4%6.4 $10.21 7/31/20231,940,000 shares $20.54 million -18.5%8.2%6.1 $10.59 7/15/20232,380,000 shares $27.89 million +15.5%10.1%7.6 $11.72 6/30/20232,060,000 shares $22.17 million -11.6%8.7%6.8 $10.76 6/15/20232,330,000 shares $29.59 million +2.6%9.9%7.6 $12.70 5/31/20232,270,000 shares $23.34 million +0.9%9.6%8.6 $10.28 5/15/20232,250,000 shares $22.37 million +0.5%9.5%10.7 $9.94 4/30/20232,240,000 shares $21.80 million +0.5%9.5%10.7 $9.73 4/15/20232,230,000 shares $22.34 million +0.5%9.5%9.9 $10.02 3/31/20232,220,000 shares $22.71 million +1.8%9.4%10.2 $10.23 3/15/20232,180,000 shares $24.44 million +3.8%7.7%10.5 $11.21 2/28/20232,100,000 shares $23.71 million +1.5%7.0%13.3 $11.29War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 2/15/20232,070,000 shares $23.91 million +6.7%6.9%13.7 $11.55 1/31/20231,940,000 shares $22.58 million -9.4%6.6%13.7 $11.64 1/15/20232,140,000 shares $23.50 million -1.8%7.2%16.4 $10.98 12/30/20222,180,000 shares $23.00 million No Change7.4%17 $10.55 12/15/20222,180,000 shares $24.96 million No Change7.4%15.9 $11.45 11/30/20222,180,000 shares $27.10 million -5.6%7.4%14.8 $12.43 11/15/20222,310,000 shares $29.48 million -4.9%8.0%14.2 $12.76 10/31/20222,430,000 shares $31.93 million -0.4%8.5%15.4 $13.14 10/15/20222,440,000 shares $30.79 million -1.2%8.5%15.7 $12.62 9/30/20222,470,000 shares $31.67 million +14.4%8.6%14.2 $12.82 9/15/20222,160,000 shares $28.21 million -13.6%7.5%10.9 $13.06 8/31/20222,500,000 shares $33.70 million No Change8.8%10.5 $13.48 8/15/20222,500,000 shares $35.40 million +2.9%8.8%8.5 $14.16 7/31/20222,430,000 shares $32.83 million -17.9%9.9%4.1 $13.51 7/15/20222,960,000 shares $43.57 million -1.7%12.1%4.9 $14.72 6/30/20223,010,000 shares $38.59 million -0.7%12.3%5.2 $12.82 6/15/20223,030,000 shares $36.09 million +6.3%12.4%5.2 $11.91 5/31/20222,850,000 shares $30.47 million +4.0%11.7%5.3 $10.69 5/15/20222,740,000 shares $29.10 million +3.8%11.2%5.7 $10.62 4/30/20222,640,000 shares $25.90 million +7.8%11.2%14.4 $9.81 4/15/20222,450,000 shares $27.44 million -3.5%10.4%13.2 $11.20 3/31/20222,540,000 shares $26.59 million -7.3%11.0%13.3 $10.47 3/15/20222,740,000 shares $34.91 million +1.5%12.1%13.2 $12.74 2/28/20222,700,000 shares $38.72 million +5.9%12.0%10.3 $14.34 2/15/20222,550,000 shares $37.69 million -3.4%11.3%9.6 $14.78 1/31/20222,640,000 shares $35.59 million -13.7%12.1%9.9 $13.48 1/15/20223,060,000 shares $41.89 million -1.0%13.4%11.4 $13.69 12/31/20213,090,000 shares $47.68 million +27.2%14.3%10.7 $15.43 12/15/20212,430,000 shares $38.71 million +3.4%11.2%9.4 $15.93 11/30/20212,350,000 shares $42.30 million -0.8%10.9%9.9 $18.00 11/15/20212,370,000 shares $49.68 million -7.8%8.1%9.3 $20.96 10/29/20212,570,000 shares $57.11 million +0.8%8.9%10.3 $22.22 10/15/20212,550,000 shares $63.75 million -1.9%8.8%10.6 $25.00 9/30/20212,600,000 shares $58.68 million +42.9%9.0%11.7 $22.57 9/15/20211,820,000 shares $52.78 million -24.5%6.3%7.6 $29.00 8/31/20212,410,000 shares $68.01 million -11.1%8.4%11.7 $28.22 8/13/20212,710,000 shares $75.09 million No Change9.5%12.4 $27.71 CGEM Short Interest - Frequently Asked Questions What is Cullinan Therapeutics' current short interest? Short interest is the volume of Cullinan Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 9,060,000 shares of CGEM short. 23.23% of Cullinan Therapeutics' shares are currently sold short. Learn More on Cullinan Therapeutics' current short interest. What is a good short interest ratio for Cullinan Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGEM shares currently have a short interest ratio of 16.0. Learn More on Cullinan Therapeutics's short interest ratio. What is a good short interest percentage for Cullinan Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 23.23% of Cullinan Therapeutics' floating shares are currently sold short. Is Cullinan Therapeutics' short interest increasing or decreasing? Cullinan Therapeutics saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 9,060,000 shares, a decrease of 1.6% from the previous total of 9,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cullinan Therapeutics' float size? Cullinan Therapeutics currently has issued a total of 57,980,000 shares. Some of Cullinan Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cullinan Therapeutics currently has a public float of 39,000,000 shares. How does Cullinan Therapeutics' short interest compare to its competitors? 23.23% of Cullinan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Cullinan Therapeutics: Xencor, Inc. (6.84%), MacroGenics, Inc. (9.26%), Black Diamond Therapeutics, Inc. (12.95%), Innate Pharma S.A. (0.07%), Bausch Health Companies Inc. (3.71%), Merus (12.93%), Rhythm Pharmaceuticals, Inc. (13.84%), Apellis Pharmaceuticals, Inc. (17.32%), Edgewise Therapeutics, Inc. (14.34%), Xenon Pharmaceuticals Inc. (4.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Cullinan Therapeutics stock? Short selling CGEM is an investing strategy that aims to generate trading profit from Cullinan Therapeutics as its price is falling. CGEM shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cullinan Therapeutics? A short squeeze for Cullinan Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CGEM, which in turn drives the price of the stock up even further. How often is Cullinan Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGEM, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies XNCR Short Interest Data MGNX Short Interest Data BDTX Short Interest Data IPHA Short Interest Data BHC Short Interest Data MRUS Short Interest Data RYTM Short Interest Data APLS Short Interest Data EWTX Short Interest Data XENE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CGEM) was last updated on 11/8/2024 by MarketBeat.com Staff From Our Partners“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI Got FiredStarting off with a few hundred bucks, it wasn't long before I started generating $1,000 a day. Then $10,00...Opportunistic Trader | SponsoredCan Trump Make Housing Great Again?Trump won. But can he undo the damage the Democrats have inflicted on this nation? Under Biden, inflatio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGEM Stock Alerts